Recent News

Bangalore BIO: BioPortEurope Makes Access To EU Markets Easy



Price Reduction Announcement.. Prices for custom peptide synt..


Neuren Set To Begin Phase III Glypromate Trials.. Australia-based Neuren Pharmac..


India, IAVI To Develop Next Gen HIV Vaccine.. Government of India and the In..


Bangalore BIO: BioPortEurope Makes Access To EU Markets Easy.. An industry is considered to h..


Loss Of Stem Cells Correlates With Premature Aging In Animal.. Loss of Stem Cells Correlates ..

All News

Feedback

An industry is considered to have arrived when allied businesses begin picking up steam


[Updated On: 08/19/2008]

An industry is considered to have arrived when allied businesses begin picking up steam. At the biotech capital of India, Bangalore, the country premier biotech show is on and among the announcements made is the low-key launch of BioPortEurope.

BioPortEurope is a one-stop-shop solution to facilitate Indian life sciences companies? entry into the European market. Considering that India?s biotech industry has touched the $2 billion mark and is slated to grow at a fast pace, the service is timely and much needed, what with a number of Indian companies aspiring to enter the global markets.

BioPortEurope provides access to a mature network of experienced life sciences professionals in The Netherlands and in the EU member states including France, Switzerland, Germany, Spain, UK, Italy, Austria and Spain via its headquarters in Amsterdam. The service is available across the areas of pharmaceuticals, generics, vaccines, diagnostics, OTC & natural products, fine chemicals and technologies.

?We are business catalysts for the industry, providing services that range from market assessments to distribution,? said Dr Maarten van Dongen. He represents InnoTact Consulting, the company that has launched the concept of BioPortEurope in India. Dr Maarten is currently in the process of scouting for an office space in India. InnoTact Consulting is likely to open office in Bangalore.